Acta Med. 2011, 54: 149-152
https://doi.org/10.14712/18059694.2016.39
Daily Prostate Volume and Position Monitoring Using Implanted Gold Markers and On-Board Imaging during Radiotherapy
References
1. DA, et al., Long-term results of the M. D. Anderson randomized doseescalation trial for prostate cancer. Int J Radiation Oncology Biol Phys. 2008; 70: 67–74.
<https://doi.org/10.1016/j.ijrobp.2007.06.054>
2. AL , et al., Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate. JAMA 2005; 294: 1233–1239.
<https://doi.org/10.1001/jama.294.10.1233>
3. DP, et al., Comparison of radiation side-effect of conformal and conventional radiotherapy in prostate cancer: a randomized trial. Lancet 1999; 353: 267–272.
<https://doi.org/10.1016/S0140-6736(98)05180-0>
4. MHP, et al., The influence of a dietary protocol on cone beam CT-guided Radiotherapy for prostate cancer patients. Int J Radiation Oncology Biol Phys. 2008; 71: 1279–1286.
<https://doi.org/10.1016/j.ijrobp.2008.03.036>
5. PR, et al., Residual set-up errors and margins in on-line image-guided prostate localization in radiotherapy. Radiotherapy and Oncology 2007; 85: 201–206.
<https://doi.org/10.1016/j.radonc.2007.08.006>
6. SJ, et al., Quantification of prostate and seminal vesicle intrefraction variation during IMRT. Int J Radiation Oncology Biol Phys. 2008; 71: 813–820.
<https://doi.org/10.1016/j.ijrobp.2007.10.028>


